FIELD: chemistry.
SUBSTANCE: in the invention, stable compositions are described, containing a modulator of a sphingosine-1-phosphate (hereinafter – S1P) receptor, which can be used as dosage forms. Modulators of S1P receptor are, as a rule, sphingosine analogues, such as 2-substituted 2-aminopropane-1,3-diol or 2-aminopropanol derivatives, for example FTY720. The introduction of pre-gelatinized starch into the composition provides for an increase in the stability.
EFFECT: obtaining compositions containing modulators of sphingosine-1-phosphate receptor.
8 cl, 11 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORGANIC COMPOUNDS | 2004 |
|
RU2358716C2 |
| ORAL PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2475237C2 |
| METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2475236C2 |
| MODULATORS OF RECEPTOR S1P FOR TREATMENT OF MULTIPLE SCLEROSIS | 2007 |
|
RU2569732C9 |
| S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
| USING SIP RECEPTOR MODULATORS IN OPHTHALMOLOGY | 2006 |
|
RU2497513C2 |
| SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
| COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
| LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
| LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
